Sign up for the QMED & MD+DI Daily newsletter.
Methods and Measurements
November 1, 2006
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "MDDI")
GOVERNMENTAL & LEGAL AFFAIRS
Intellectual property research and advisory services firm iplQ (Chicago) uses proprietary data, tools, analytics, and technology to identify the power, speed, and industry impact of medical device patents. The company's indicators measure patent and portfolio strength and technical innovation at company, industry, and regional levels. The following indicators were highlighted in ipIQ's recent analysis of medical device patents by state and core-based statistical area.
Technology Strength: Provides an overall assessment of intellectual property and innovation by considering a portfolio's quality and quantity aspects.
Current Impact Index (CII): Showcases the broader significance of a company's patent portfolio by examining how influential its patents are across the industry and in specific product categories. It measures a portfolio's importance as a foundation for other patents and technologies.
Science Linkage: Reflects the core science referenced in a company's U.S. patents, as measured by the average number of science literature references listed in the patents. A high figure indicates the company is closer to cutting-edge research than its competitors.
Technology Cycle Time: Indicates a firm's speed in turning proprietary research and innovation into intellectual property.
Patent Count: Equals the number of U.S. patents awarded, excluding design and other special-case inventions.Copyright ©2006 MX
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)
